Laws And Regulations

Type	Signature	Number	Date	Topic	Document
Circular	Minister of Public Health	9	9-3-2022	Related to providing specialized mental health medications in primary health care centers	Circular Number 9: Related to providing specialized mental health medications in primary health care centers
Decision	Minister of Public Health	271/1	25/02/2019	Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital	Decision Number 271/1: Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital
Decision	Minister of Public Health	270/1	25/02/2019	Related to the Quality of Care and Human Rights in the Field of Mental Health	Decision Number 270/1: Related to the Quality of Care of Human Rights in the Field of Mental Health
Circular	Director General	60	20/06/2018	Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system	Circular Number 60: Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system
Circular	Director General	112	27/11/2018	Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health	Circular Number 112: Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health
Circular	Director General	113	22/11/2018	Related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)	Circular number 113: related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)
Decision	Minister of Public Health	1155	19-06-2018	Decision related to the National Mental Health Programme	Decision number 1155: related to the National Mental Health Programme
Circular	Director General	22	09-03-2018	Regulation of studies and research in the field of mental health and psychosocial support	Circular number 22: related to the regulation of studies and research in the field of mental health and psychosocial support
Annexe		1320/1	02-2018	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.
Circular	Director General	48	12-06-2017	Regulation of research in the field of mental health	Circular number 48: Related to the regulation of research in the field of mental health
Circular	Director General	64	12-06-2017	Projects related to MHPSS and substance use in Lebanon	Circular number 64: Projects related to MHPSS and substance use in Lebanon
Circular	Director General	46	22-03-2016	Request to hospitals to not report on overdose	Circular number 46: related to the request to hospitals to not report on overdose
Circular	Director General	66	20-6-2025	Regarding Specialized Mental Health Medications	Circular number 66: Concerning Specialized Mental Health Medications

ATC	Name	B/G	Ingredients	Form	Price
N07BC51	SUBOXONE	G	Buprenorphine HCl - 16mg, Naloxone HCl - 4mg	Tablet, sublingual	14,284,125 L.L
S01XA20	LUBRI-TEARS	G	Carmellose sodium - 2mg	Drops solution	792,867 L.L
B05BB01	R-SOL	G	Calcium chloride, 2H2O - 0.033%, Potassium chloride - 0.03%, Sodium chloride - 0.86%	Injectable solution	205,933 L.L
B05ZA	CONCENTRATE SOLUTION FOR HEMODIALYSIS L	G	Potassium chloride - K+:1.5 mmol/l, Magnesium chloride - Mg++:0.75 mmol/l, Calcium chloride - Ca++:1.75 mmol/l, Sodium acetate - Cl-:106.5 mmol/l, Sodium chloride - Na+:135 mmol/l	Injectable solution	L.L
C09DB06	LOSANET AM	G	Losartan potassium - 100mg, Amlodipine - 10mg	Tablet	1,044,358 L.L
J01DD52	ZAVICEFTA	B	Ceftazidime - 2g, Avibactam - 0.5g	Injectable powder for concentrate for solution	101,659,975 L.L
B05BB01	SERUFLEX RINGER'S INJECTION, USP	G	Calcium chloride, 2H2O - 0.33g/l, Potassium chloride - 0.3g/l, Sodium chloride - 8.6g/l	Injectable solution	204,554 L.L
B05ZA	CONCENTRATE SOLUTION FOR HEMODIALYSIS LM	G	Potassium chloride - K+:2.00 mmol/l, Magnesium chloride - Mg++:0.75 mmol/l, Calcium chloride - Ca++:1.75 mmol/l, Sodium acetate - Cl-:112 mmol/l, Sodium chloride - Na+:140 mmol/l	Injectable solution	L.L
C09DB06	LOSANET AM	G	Losartan potassium - 100mg, Amlodipine - 5mg	Tablet	1,044,358 L.L
B05BB01	SOLUFLEX RINGER'S INJECTION, USP	G	Calcium chloride, 2H2O - 0.33g/l, Potassium chloride - 0.3g/l, Sodium chloride - 8.6g/l	Injectable solution	221,792 L.L
B05ZA	CONCENTRATE SOLUTION FOR HEMODIALYSIS LS	G	Potassium chloride - K+:1.5 mmol/l, Magnesium chloride - Mg++:0.75 mmol/l, Calcium chloride - Ca++:1.75 mmol/l, Sodium acetate - Cl-:111.5 mmol/l, Sodium chloride - Na+:140 mmol/l	Injectable solution	L.L
C09DB07	CANDAM	G	Candesartan cilexetil - 8mg, Amlodipine - 5mg	Capsule, hard	1,376,095 L.L
B05BB02	5% DEXTROSE 0.9% SODIUM CHLORIDE INJECTION	G	Dextrose,H2O - 5g/100ml, Sodium chloride - 0.9g/100ml	Injectable solution	180,421 L.L
B05ZA	CONCENTRATE SOLUTION FOR HEMODIALYSIS LS2	G	Potassium chloride - K+:1.5 mmol/l, Magnesium chloride - Mg++:0.75 mmol/l, Calcium chloride - Ca++:1.5 mmol/l, Sodium acetate - Cl-:111 mmol/l, Sodium chloride - Na+:140 mmol/l	Injectable solution	L.L
C09DB07	CORONOPINE	G	Candesartan cilexetil - 8mg, Amlodipine - 5mg	Capsule, hard	1,368,032 L.L
H02B	PREDALONE PLUS	G	Prednisolone sodium phosphate - 10mg/5ml, Dexchlorpheniramine maleate - 2mg/5ml	Syrup	890,776 L.L
S02AA30	TYOTOCIN	B	Hexylresorcinol - 0.1%, Antipyrine - 5%, Benzocaine - 1.25%, Tyrothricin - 0.05%	Drops solution	409,552 L.L
B05BB02	5% DEXTROSE 0.9% SODIUM CHLORIDE INJECTION	G	Dextrose,H2O - 5g/100ml, Sodium chloride - 0.9g/100ml	Injectable solution	226,388 L.L
B05ZA	CONCENTRATE SOLUTION FOR HEMODIALYSIS LS3	G	Potassium chloride - K+:2.00 mmol/l, Magnesium chloride - Mg++:0.75 mmol/l, Calcium chloride - Ca++:1.60 mmol/l, Sodium acetate - Cl-:112 mmol/l, Sodium chloride - Na+:140 mmol/l	Injectable solution	L.L
C09DB07	CANDAM	G	Candesartan cilexetil - 16mg, Amlodipine - 5mg	Capsule, hard	1,376,095 L.L
S02AA30	OTOCOL	G	Chloramphenicol - 50mg/ml, Benzocaine - 50mg/ml	Drops	163,949 L.L
B05BB02	5% DEXTROSE 0.9% SODIUM CHLORIDE INJECTION	G	Dextrose,H2O - 5g/100ml, Sodium chloride - 0.9g/100ml	Injectable solution	153,990 L.L
B05ZA	CONCENTRATE SOLUTION FOR HEMODIALYSIS R	G	Potassium chloride - K+:1.00 mmol/l, Magnesium chloride - Mg++:0.75 mmol/l, Calcium chloride - Ca++:1.40 mmol/l, Sodium acetate - Cl-:105.8 mmol/l, Sodium chloride - Na+:140.5 mmol/l	Injectable solution	L.L
C09DB07	CORONOPINE	G	Candesartan cilexetil - 16mg, Amlodipine - 5mg	Capsule, hard	1,638,144 L.L
G03CC06	GYNOFLOR	B	Estriol - 0.03mg, Lactobacillus acidophillus - 10 MIU	Tablet	813,025 L.L
S02CA02	VIOCORTENE	B	Clioquinol - 10mg/ml, Flumetasone pivalate - 0.2mg/ml	Drops	568,253 L.L
B05BB02	DEXTROSE 5% & SODIUM CHLORIDE 0.9%	G	Sodium chloride - 0.9g/100ml, Dextrose, H2O - 5g/100ml	Injectable solution	189,262 L.L
B05ZA	CONCENTRATE SOLUTIONFOR HEMODIALYSIS TYPE A	G	Hemodialytics, concentrates -	Injectable solution	L.L
C09DB07	CANDAM	G	Candesartan cilexetil - 16mg, Amlodipine - 10mg	Capsule, hard	1,376,095 L.L
D04AA32	DERMAMINE ITCH STOPPING	G	Diphenhydramine HCl - 1%, Zinc acetete - 0.1%	Cream	560,382 L.L